68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

August 31, 2021

Conditions
PET/CTProstate Specific Membrane AntigenIMAGE
Interventions
DEVICE

total-body PET/CT

PCa patients who underwent PSMA PET/CT in our clinical center received two-time points scans at 1 h p.i. and 3 h p.i. on a total-body PET/CT scanner.

Trial Locations (1)

200127

Shanghai jiaotong University School of Medicine, Renji Hospital, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT05134064 - 68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer | Biotech Hunter | Biotech Hunter